Concepedia

Shinya Fujiki

SF

Statistics

Publications

6

Citations

219

H-Index

6

Active since

2020

Affiliations

Niigata University(Current)

Juntendo University

Japan Agency for Medical Research and Development

Hokkaido University

National Cerebral and Cardiovascular Center

Shinya Fujiki is an author at Niigata University specializing in sodium-glucose cotransporter 2 inhibitors, cardiovascular pharmacotherapy, and sodium-glucose cotransporter 2 inhibition.

ORCID

Publications per year

2020–2024

6

Publications

6

SGLT2 inhibition eliminates senescent cells and alleviates pathological aging

Goro Katsuumi, Ippei Shimizu, Masayoshi Suda et al. · Nature Aging · 2024 · 126 citations · Full text

, , +17

Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial

Shinya Fujiki, Kenichi Iijima, Yoshihisa Nakagawa et al. · Cardiovascular Diabetology · 2024 · 30 citations · Full text

, , +16

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design

Shinya Fujiki, Kenichi Iijima, Masaaki Okabe et al. · Diabetes Therapy · 2020 · 21 citations · Full text

, , +17

Body fluid regulation via chronic inhibition of sodium–glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial

Shinya Fujiki, Atsushi Tanaka, Takumi Imai et al. · Clinical Research in Cardiology · 2022 · 16 citations

, , +15

Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity

Yuka Hayashi, Ippei Shimizu, Yohko Yoshida et al. · iScience · 2022 · 14 citations · Full text

, , +17

1–5 of 6